http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-1535215-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_97a285d8ecd0184a7e5d89a1e4e07997
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-55
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H15-234
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B01J23-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7008
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H15-236
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H15-234
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07B61-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
filingDate 1975-12-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1978-12-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber GB-1535215-A
titleOfInvention Kanamycin derivatives
abstract Semisynthetic derivatives of kanamycin A and B of the formula IV in which R3 and R have the meaning stated in Claim 1 are prepared. The process starts from corresponding compounds with R = hydrogen and comprises acylation with an acylating agent of the formula VII in which W and M have the meaning stated in Claim 1, and subsequent elimination of the amino protective group W. A preferred acylating agent of the formula VIIa is obtained in situ by mixing the appropriate N-protected carboxylic acid with equimolar amounts of N-hydroxy-5-norbornene-2,3-dicarboximide and dicyclohexylcarbodiimide as dehydrating agent. The said compounds have antibacterial activity and can therefore be used in medicines or as additives to animal feedstuffs. <IMAGE>
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8524689-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8653042-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8822424-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11117915-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8658606-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9688711-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9266919-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-RE47741-E
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8492354-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8383596-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8524675-B2
priorityDate 1974-12-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID89529
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419555718
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10868
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396401
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415786943
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439318
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419493484
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419585914
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6032

Total number of triples: 38.